Graham Dunkley chooses Medica’s Pharma Cartons
March 1, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Medica Packaging
Medica Packaging is pleased to announce that Graham Dunkley, most recently of Multi Packaging Solutions (MPS) has joined Medica as …
Promising anti-cocaine treatment aims for human trials within a year
March 1, 2017Research and Development University of Cincinnati, cocaine, immunotherapy
Researchers at the University of Cincinnati (UC) have developed a monocloncal antibody designed to treat cocaine addiction; its successful showing …
Asthma drugs may have alternative function as pneumonia treatment
March 1, 2017Research and Development asthma, influenza, pneumonia
Researchers from the University of Virginia School of Medicine have discovered that two drugs commonly used to treat asthma, Accolate …
Kite Pharma climbs on strong data showing in lymphoma trial
March 1, 2017Research and Development kite pharma, non-Hodgkin lymphoma
Kite Pharma released the news on Rare Diseases Day promising top-line data from a Phase 1/2 trial of its treatment …
Novo Nordisk’s Head of North America resigns
March 1, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, appointment
Novo Nordisk has announced the surprising news that its Executive Vice President, Head of North American Operations Jakob Riis has …
NICE knocks back MSD’s Keytruda for lung cancer indication
February 28, 2017Research and Development, Sales and Marketing MSD, NICE, NSCLC, keytruda
MSD’s immunotherapy drug Keytruda (pembrolizumab) has been knocked back by the National Institute of Health and Care Excellence (NICE) for …
WHO releases list of bacteria that pose greatest threat to humankind
February 28, 2017Research and Development WHO, antibiotic resistance
The World Health Organisation (WHO) has published a list of the 12 bacteria that are thought to present the largest …
FDA green lights AstraZeneca type-2 diabetes drug
February 28, 2017Manufacturing and Production, Sales and Marketing AstraZeneca, FDA
AstraZeneca has announced that its type-2 diabetes treatment Qtern (10mg dapagliflozin and 5mg saxagliptin) has received the approval of the …
J&J latest pharma firm to volunteer pricing data
February 28, 2017Manufacturing and Production, Medical Communications J&J, JJ, Johnson & Johnson
Johnson & Johnson released its pricing data, as promised, in February and it has simply revealed that its average price …
Sanofi and Lonza partner up for €270m biologics facility
February 28, 2017Manufacturing and Production Lonza, Sanofi
Sanofi and Lonza have announced they are to join forces in a strategic partnership which will see the establishment of …
Huge data loss puts NHS privatisation and Health Secretary under pressure
February 28, 2017Manufacturing and Production Jeremy Hunt, NHS, data
It has been revealed that a private company, responsible for delivering NHS data, accidentally stored 708,000 pieces of patient data …
EMA recommends expanded indication for Janssen multiple myeloma drug
February 27, 2017Manufacturing and Production, Research and Development, Sales and Marketing Janssen, darzalex
The European Medicines Agency’s Committee for Medicinal Products for Human Use has given its positive opinion for the use of …
La Jolla finds potential jewel in successful Phase 3 trial
February 27, 2017Manufacturing and Production, Research and Development La Jolla pharmaceutical
La Jolla Pharmaceutical, a biotech company based in San Diego, US, received a boost to both its shares and its …
Moderna Therapeutics instates MIT Treasurer to Board of Directors
February 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MIT, Moderna, Moderna Therapeutics
Moderna Therapeutics, a clinical stage biotechnology company, has announced the appointment of Israel Ruiz to the company’s Board of Directors. …
Does Trump pose a threat to the FDA’s future?
February 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Trump
President Trump’s first month in office made headlines across the industry just as it did in the wider media. Promises …
MSD’s investigational cytomegalovirus treatment shows significant promise in Phase 3 trial
February 27, 2017Research and Development, Sales and Marketing MSD, cytomegalovirus, letermovir
MSD has lifted the curtain on strong Phase 3 results in the development of its investigational antiviral drug letermovir, showing …
Assay opens way to autoantibodies treatment for rheumatoid arthritis
February 27, 2017Research and Development, Sales and Marketing rheumatoid arthritis
A new discovery, conducted by researchers at the NYU Langone Medical Center and the University of Pittsburgh, has pointed towards …
Cuba begins Phase 1 testing of HIV vaccine
February 27, 2017Research and Development, Sales and Marketing Cuba, HIV
Cuba has announced that it has begun testing a HIV vaccine that looks to reduce the ‘payload’ of the virus …
EFPIA names first female Director General
February 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EFPIA
Industry trade organisation the European Federation of Pharmaceutical Industries and Associations (EFPIA) has announced the appointment of Nathalie Moll as …
Weight loss drug reduces diabetes risk by 80%, according to ICL research
February 27, 2017Research and Development, Sales and Marketing diabetes, icl, liraglutide
Researchers from Imperial College London have published research showing that use of weight loss drug liraglutide lowered the risk of …
Latest content
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?
